Trump promises to reduce US medicine prices to world's lowest | Fin24
 
  • Mandela Day

    Nationalisation, privatisation and land: What Mandela told business in 1990 still resonates today.

  • African Foothold

    American multinational PepsiCo has agreed to buy South Africa’s Pioneer Foods for about R24.4bn.

  • Fin24’s newsletter

    Sign up to receive Fin24's top news in your inbox every morning.

Loading...

Trump promises to reduce US medicine prices to world's lowest

Jul 06 2019 15:00
AFP

US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the lowest in the world.

"We're working on a favoured nations law where we pay whatever the lowest nation's price is," Trump told reporters from the White House South Lawn. "As you know, for years and years other nations paid less for drugs than we do, sometimes by 60%, 70%," he said.

The president accused pharmaceutical companies of having "taken advantage of the system for a long time," with US drug prices often exceeding those in neighboring Canada and Mexico as well as Europe. 

"Why should other nations like Canada - why should other nations pay much less than us?" Trump said, declaring that he would handle the matter "in the form of an executive order."

Beginning this month the United States will require pharmaceutical companies to disclose the price of their drugs during television commercials, a measure which Trump has praised for its "historic transparency."

About half of Americans have health insurance with a high deductible which can reach thousands of dollars a year, in many cases more than $5 000 or $6 000 annually.

Many have to pay the full drug price until they have spent their annual deductible amount.

Despite pressure from the president, US pharmaceutical giant Pfizer in January increased the price of 41 drugs, which represents 10 percent of its drug portfolio.

As with other pharmaceutical companies, Pfizer is facing the loss of patents for some of its biggest blockbuster drugs. Manufacturers are justifying a hike in prices saying they need to pay for research and development.


pfizer  |  donald trump  |  canada  |  us  |  us economy  |  trade
NEXT ON FIN24X

 
 
 
 

Company Snapshot

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

FaceApp has been at the centre of a debate on data security. What is your view?

Previous results · Suggest a vote

Loading...